CTRI/2021/12/039054已完成4 期
A multicentric, longitudinal study on measurement of Immune Responses in Multisystem Inflammatory Syndrome in Children (MIS-C)
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Study group:
- •Patients diagnosed to be MIS-C cases by the treating physicians and co-investigators at the three collaborating centres (Kasturba Medical College, Manipal; Kasturba Medical College, Mangalore and Ramaiah Medical College, Bangalore) as per the WHO case definition.
- •Control groups:
- •There will be three sub-groups in this:
- •A) SARS-CoV-2 RT PCR positive patients in the age group, 0 – 19, not fitting into the WHO case definition of MIS-C.
- •B) Age matched healthy controls who are negative for SARS-CoV-2 RT-PCR and do not have signs and symptoms of any ongoing infection.
- •C) Children were classified as having complete/incomplete Kawasaki Disease (KD) by using American Heart Association criteria
排除标准
- •Subjects on immunomodulatory therapy for samples obtained following the first visit to the treating physician
研究者
相似试验
尚未招募
Unknown
A multicenter observational study for measurement of SNPs in participants of the Japan Polyp Study CohortColorectal cancerJPRN-UMIN000049978ational Cancer Center Hospital1,230
未知
Unknown
Observational Study in Patients With Autosomal Dominant Polycystic Kidney DiseaseAutosomal dominant polycystic kidney disease (ADPKD)JPRN-jRCT1080221699Otsuka Pharmaceutical Dvelopment & Commercialization, Inc.3,000
已完成
4 期
A Multi-center, Longitudinal, Observational Study of Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) to Establish the Rate, Characteristics, and Determinants of Disease ProgressioADPKDautosomal polycystic kidney disease10029149NL-OMON36219Otsuka America Pharmaceutical100
招募中
不适用
The study on prognosis in patients with fatty liverJPRN-UMIN000046497Yokohama City University3,000
已完成
不适用
MULTICENTER, OBSERVATIONAL, LONG-TERM STUDY ON THE IMPACT OF THE THERAPEUTIC DECISION TAKEN IN PATIENTS RECEIVING A TRANSPLANT OF SOLID ORGAN, WHO WILL RECEIVE SANDIMMUN NEORAL IN CIRCUMSTANCES OF NORMAL CLINICAL PRACTICE.-Z94Z94PER-048-02OVARTIS BIOSCIENSES PERU S.A.,
